Healio compiles top stories for Hyperpigmentation/Melasma Awareness Month
Click Here to Manage Email Alerts
Healio has compiled stories for Hyperpigmentation/Melasma Awareness Month, held every year in July.
Stories include a feature on the benefits of permanent makeup on hyperpigmentation and other types of dermatological conditions, the effects of trifarotene cream and complications from Mohs surgery resulting in hyperpigmentation.
Q&A: Dermatologists can use power of permanent makeup to physically, mentally aid patients
Many patients who suffer from dermatological conditions, including hyperpigmentation, could benefit from the wonders of makeup — specifically permanent makeup. In this article, Healio spoke with Walter Liszewski, MD, FAAD, assistant professor of dermatology and preventative medicine at Northwestern Feinberg School of Medicine, about how permanent makeup can benefit these patients, both physically and mentally. Read more.
Trifarotene cream with proper skin care reduces acne-induced hyperpigmentation
A study published in the International Journal of Dermatology found that trifarotene cream 0.005%, in conjunction with a proper skincare regimen, reduced acne lesions and acne-induced hyperpigmentation within 24 weeks. Read more.
Mohs surgery techniques may cause hyperpigmentation among patients with skin of color
Procedural factors, including the use of grafts and granulation as well as postoperative complications, influence post-inflammatory hyperpigmentation following Mohs micrographic surgery among patients with skin of color. Read more.
Dapsone gel 7.5% safe, effective for acne treatment in patients with skin of color
Since patients with skin of color tend to experience high rates of hyperpigmentation, researchers conducted a study on dapsone gel 7.5%. Results showed that the gel demonstrated safety, tolerability and efficacy for the treatment of acne vulgaris in patients with skin of color. Read more.
Cysteamine isobionic-amide may be alternative to modified Kligman’s formula for melasma
A study published in the Journal of Drugs in Dermatology, cysteamine isobionic-amide combination showed similar efficacy and superior quality of life improvement to modified Kligman’s formula for the treatment of melasma. Read more.